- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 20, 2023
Deals
Dec. 19 Quick Takes: Ionis, Otsuka in European deal for HAE therapy
Plus: Carmot spinout Kimia raises $55M series A round, CureVac tumbles on loss in patent case and more from Lassen, Atavistik, Crinetics, Merck and CSL
BioCentury | Aug 18, 2022
Deals
August 17 Quick Takes: Viridian raises $270M in upsized follow-on
Plus CSL readying HAE mAb for regulators and updates from AbbVie, GSK and WHO
BioCentury | Jul 9, 2020
Product Development
CSL testing coagulation factor blocker in COVID-19 patients; plus vaccine deals and plasma trials
BioCentury | Jun 12, 2020
Product Development
June 11 Quick Takes: Sobi licenses Selecta gout therapy; plus Viela’s first approval, CSL, BMS, Sirnaomics’ spinout, Denali-Sanofi
BioCentury | Nov 15, 2019
Financial News
Atomwise JV raises $14.5M series A to advance AI-discovered candidates
BioCentury | Jul 20, 2017
Preclinical News
Team develops conjugation strategy for longer-lived peptides
Items per page:
1 - 10 of 11